/BITRF
BITRF Stock - Biotron Limited
Healthcare|BiotechnologyOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.2
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BITRF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.93
52W High$0.10
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.81M | $1.65M | $1.43M | $1.56M | $1.46M |
| Gross Profit | $1.81M | $1.60M | $1.39M | $1.51M | $1.41M |
| Gross Margin | 100.0% | 97.5% | 97.0% | 97.1% | 96.8% |
| Operating Income | $-338,751 | $-3,506,063 | $-3,608,041 | $-2,776,034 | $-3,193,086 |
| Net Income | $-318,572 | $-3,436,524 | $-3,492,766 | $-2,781,083 | $-3,194,347 |
| Net Margin | -17.6% | -208.9% | -244.0% | -178.4% | -218.5% |
| EPS | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
Company Overview
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BITRFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2025
EPS Surprise History
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q2 24
No data
Q3 24
No data
Q1 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 26, 2026 | — | — | — | — |
Q3 2025 | Sep 1, 2025 | — | $-0.00 | — | — |
Q1 2025 | Feb 25, 2025 | — | $0.00 | — | — |
Q3 2024 | Aug 29, 2024 | — | $-0.00 | — | — |
Q2 2024 | Apr 26, 2024 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q4 2020 | Dec 30, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.00 | — | — |
Q4 2019 | Dec 30, 2019 | — | $-0.00 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.00 | — | — |
Q4 2018 | Dec 30, 2018 | — | $-0.00 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.00 | — | — |
Q4 2017 | Dec 30, 2017 | — | $-0.00 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.00 | — | — |
Q4 2016 | Dec 30, 2016 | — | $-0.00 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BITRF
What is BITRF's current stock price?
Biotron Limited (BITRF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for BITRF?
No analyst price targets are currently available for this stock.
What sector is Biotron Limited in?
Biotron Limited operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is BITRF's market cap?
Biotron Limited has a market capitalization of $0.00 billion, making it a small-cap company.
Does BITRF pay dividends?
No, Biotron Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBNGI
Bangi Inc.
$0.00
Mkt Cap: $0.0B
BPTSY
Biophytis S.A.
$0.00
Mkt Cap: $0.0B
DYNT
Dynatronics Corporation
$0.04
Mkt Cap: $0.0B
GRCU
Green Cures & Botanical Distribution Inc.
$0.00
Mkt Cap: $0.0B
MCET
MultiCell Technologies, Inc.
$0.00
Mkt Cap: $0.0B
MDNWF
Mednow Inc.
$0.02
Mkt Cap: $0.0B
PFND
Pathfinder Cell Therapy, Inc.
$0.00
Mkt Cap: $0.0B
TSOI
Therapeutic Solutions International, Inc.
$0.00
Mkt Cap: $0.0B
VIRX
Viracta Therapeutics, Inc.
$0.01
Mkt Cap: $0.0B
YECO
Yulong Eco-Materials Limited
$0.08
Mkt Cap: $0.0B
Explore stocks similar to BITRF for comparison